RAC 2.92% $1.94 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-62

  1. 2,156 Posts.
    lightbulb Created with Sketch. 292
    Great news for shareholders. but on a bigger note, this is the part that stuck a chord with me

    "...it may also help patients who have exhausted other treatment options."
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.